Authors:
SCHREINER PJ
SALOMAA VV
RASI VP
PIETINEN P
VAHTERA EM
KLEEMOLA P
HAUKKALA A
MYLLYLA G
Citation: Pj. Schreiner et al., DIETARY-FAT INTAKE AND HEMOSTASIS AMONG PARTICIPANTS IN THE 1992 FINRISK HEMOSTASIS SURVEY, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 8(1), 1998, pp. 21-30
Authors:
KASTARINEN MJ
SALOMAA VV
VARTIAINEN EA
JOUSILAHTI PJ
TUOMILEHTO JO
PUSKA PM
NISSINEN AM
Citation: Mj. Kastarinen et al., TRENDS IN BLOOD-PRESSURE LEVELS AND CONTROL OF HYPERTENSION IN FINLAND FROM 1982 TO 1997, Journal of hypertension, 16(9), 1998, pp. 1379-1387
Authors:
SALOMAA VV
MATEL C
ALEKSIC N
SANSORESGARCIA L
FOLSOM AR
JUNEJA H
CHAMBLESS LE
WU KK
Citation: Vv. Salomaa et al., SOLUBLE THROMBOMODULIN AS A PREDICTOR OF INCIDENT CORONARY HEART-DISEASE - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY, Circulation, 98(17), 1998, pp. 2756-2756
Authors:
SALOMAA VV
SALMINEN I
RASI V
VAHTERA E
ARO A
MYLLYLA G
Citation: Vv. Salomaa et al., ASSOCIATION OF THE FATTY-ACID COMPOSITION OF SERUM PHOSPHOLIPIDS WITHHEMOSTATIC FACTORS, Arteriosclerosis, thrombosis, and vascular biology, 17(5), 1997, pp. 809-813
Authors:
SHAHAR E
FOLSOM AR
SALOMAA VV
STINSON VL
MCGOVERN PG
SHIMAKAWA T
CHAMBLESS LE
WU KK
Citation: E. Shahar et al., RELATION OF HORMONE-REPLACEMENT THERAPY TO MEASURES OF PLASMA FIBRINOLYTIC-ACTIVITY, Circulation, 93(11), 1996, pp. 1970-1975
Citation: Pj. Schreiner et al., RELIABILITY OF NEAR-INFRARED INTERACTANCE BODY-FAT ASSESSMENT RELATIVE TO STANDARD ANTHROPOMETRIC TECHNIQUES, Journal of clinical epidemiology, 48(11), 1995, pp. 1361-1367
Authors:
SALOMAA VV
LIAO DP
KARK JD
WU KK
STINSON V
FOLSOM AR
DAVIS CE
Citation: Vv. Salomaa et al., THE ASSOCIATION OF 3 PARAMETERS OF FIBRINOLYSIS WITH FASTING INSULIN,GLUCOSE AND TRIGLYCERIDES - THE ARIC STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 1149-1149
Authors:
SALOMAA VV
SALMINEN I
RASI V
ARO A
VAHTERA E
PEKKANEN J
MYLLYLA G
Citation: Vv. Salomaa et al., THE ASSOCIATION OF THE FATTY-ACID COMPOSITION OF SERUM PHOSPHOLIPIDS WITH HEMOSTATIC FACTORS, Thrombosis and haemostasis, 73(6), 1995, pp. 1391-1391
Authors:
MIETTINEN H
NIEMELA M
LEHTO S
HAFFNER SM
SALOMAA VV
MAHONEN M
TUOMILEHTO J
Citation: H. Miettinen et al., SHORT AND LONG-TERM CASE-FATALITY OF MYOCARDIAL-INFARCTION IN DIABETIC AND NONDIABETIC PATIENTS, Diabetologia, 38, 1995, pp. 20-20
Citation: Vv. Salomaa et H. Miettinen, INCIDENCE OF AND MORTALITY FROM ACUTE MYOCARDIAL-INFARCTION IN FINLAND IN 1983-1992 - PRINCIPAL RESULTS OF THE FINMONICA-AMI REGISTER, Circulation, 91(3), 1995, pp. 937-937
Citation: H. Miettinen et Vv. Salomaa, NO MAJOR CHANGES IN CASE-FATALITY OF ACUTE MYOCARDIAL-INFARCTION IN FINLAND DURING 1983-92 - RESULTS OF THE FINMONICA STUDY, Circulation, 91(3), 1995, pp. 938-938
Authors:
STRANDBERG TE
SALOMAA VV
VANHANEN HT
NAUKKARINEN VA
SARNA SJ
MIETTINEN TA
Citation: Te. Strandberg et al., MORTALITY IN PARTICIPANTS AND NON-PARTICIPANTS OF A MULTIFACTORIAL PREVENTION STUDY OF CARDIOVASCULAR-DISEASES - A 28-YEAR FOLLOW-UP OF THEHELSINKI BUSINESSMEN STUDY, British Heart Journal, 74(4), 1995, pp. 449-454
Authors:
SHAHAR E
FOLSOM AR
SALOMAA VV
STINSON VL
MCGOVERN PG
SHIMAKAWA T
CHAMBLESS LE
WU KK
Citation: E. Shahar et al., RELATION OF HORMONE REPLACEMENT THERAPY TO PARAMETERS OF ENDOGENOUS FIBRINOLYTIC-ACTIVITY - ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY, Circulation, 89(2), 1994, pp. 940-940
Authors:
STRANDBERG TE
SALOMAA VV
VANHANEN HT
NAUKKARINEN V
SAMA S
MIETTINEN TA
Citation: Te. Strandberg et al., LONG-TERM MORTALITY IN PARTICIPANTS AND NONPARTICIPANTS OF A MULTIFACTORIAL PRIMARY PREVENTION TRIAL, Circulation, 88(4), 1993, pp. 635-635